Ampio Pharmaceuticals is currently weaving the gauntlet of a clinical hold triggered by COVID's disruption to clinical studies of its lead candidate Ampion, and recently launched an independent investigation into that trial and others. On this episode, Ampio Pharmaceuticals chairman and CEO Mike Martino joins the Business of Biotech for a candid discussion on the company, the candidate, the disruption, and the go-forward plan.
Business Of Biotech
·
56
minutes
·
9 months ago
Inflammation & Antibodies with Ampio Pharmaceuticals' Mike Martino, CEO
Similar podcasts
Life Sciences Connect
Life Sciences Connect explores the big issues, the emerging trends and the cutting edge innovations that are shaping the Life Sciences industry. Each month, we will connect with industry experts and leaders from the Biotech, Pharmaceutical and Medical Devices industries to discus...
Explore Life Sciences
The life sciences industry is one of the fastest-growing communities in the world and we aim to shine a light on some amazing personalities.
A monthly podcast where multiple members of the life science industry come together to explore and discuss opinions, developments and share...
CEO Warrior Podcast with Mike Agugliaro
THE podcast dedicated to Service Industry owners, so they can achieve more wealth, freedom and market domination.
Management Information Science
The MIS Podcast blends Technology and Business to help professionals learn more about common and up and coming technologies.
Life During Covid
This is an educational podcast in which I talk about one of the most important topics of today: COVID-19.
Collective Evolution with Joe Martino
We explore new and emerging ideas in philosophy, well-being, human potential, consciousness and more as we seek clarity and direction through heavily changing times.
Virtually every aspect of our society is crumbling or transitioning – media, technology, consciousness, economie...
Comments (0)